-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: June 2012
Implementing the WHO PIP Framework – Industry’s Role & Outlook
In May 2011, the World Health Organization (WHO) adopted the Pandemic Influenza Preparedness (PIP) Framework after nearly five years of contentious negotiations. As noted by Anne Huvos, WHO Secretariat, the two objectives of the PIP Framework are: (1) to improve sharing of influenza viruses with human pandemic potential; and (2) to achieve more predictable, efficient, and equitable access to benefits, such as vaccines and antiviral medicines, during future pandemics. The subject of a session at Read More >
Business Confidence with the RFS Under Attack
This week, Biofuels Digest and BIO launched the quarterly Bioenergy Business Outlook Survey. Results from the first quarter of 2012 showed that industry optimism remained high earlier in the year, even though companies still reported difficulty in raising the capital needed for ongoing research and development and construction of demonstration and commercial biorefineries. Now that the petroleum refiners have launched a multi-million dollar pr campaign against the biofuel industry, it will be interesting to take Read More >
Biofuels & Climate Change
Leave a comment
Email This Post
Tags: 2011 Bioenergy Business Outlook Survey, 2012 BIO International Convention, Bioenergy Business Outlook Survey, biofuel, Biofuel Technology, biofuels, Biofuels Digest, biotech industry, Biotechnology Industry, Industry Analysis, renewable fuel standard
Tags: 2011 Bioenergy Business Outlook Survey, 2012 BIO International Convention, Bioenergy Business Outlook Survey, biofuel, Biofuel Technology, biofuels, Biofuels Digest, biotech industry, Biotechnology Industry, Industry Analysis, renewable fuel standard
#Partnering Wrap Up for BIO International Convention
A very big thank you to all the companies, sponsors, and attendees of the BIO Business Forum and Exhibitor Partnering. We’re very excited at the level of activity, feedback, and business getting done, right in the biotech hub of Boston. As you know, we scheduled over 25,000 meetings. Here are the official stats, as of this morning: Total Requests 127,635 Scheduled Meetings 25,291 Companies 2,900 Countries 58 What do those stats really mean? Here’s the Read More >
BIO Official Blogger Roundup
Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Cross Border Biotech – Now on Video, The Cross-Border Biotech Blog Alberta, BIO, Biotech and Business, GenomeAlberta The Long and Sometimes Winding Road to Humanitarian of the Year, GenomeAlberta Alberta Company Helps Diabetics Put Their Best Food Forward, GenomeAlberta Metabolomics Technology Tackles Cancer, GenomeAlberta Pre-competitive collaboration brings medicines to patients, LillyPad Widespread praise for US drug bill, Read More >
Analysis and Impact of PDUFA V
As the House of Representatives voted unanimously to approve legislation to approve the Prescription Drug User Fee Act (PDUFA) V, industry leaders gathered at the 2012 BIO International Convention for a lively discussion on the changes the new legislation, focused on modernizing Food and Drug Administration regulations, will bring to the biotechnology industry. The super session panel discussion was moderated by Steve Usdin, Washington Editor of BioCentury and Co-Host of BioCentury This Week, and included Read More >
